SEC Form 4 · accession 0001171843-17-004467
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph G Darling
Officer — President
Period of report
Jul 27, 2017
Accepted (ET)
Jul 31, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 27, 2017 | A | 14,506 | $0.00 | A | 14,506 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $51.70 | Jul 27, 2017 | A | 41,609 | A | — | Jul 27, 2027 | Common Stock | 41,609 | 41,609 | D |
Explanation of responses
- F1Restricted stock awards vest in three equal annual installments beginning July 27, 2018.
- F2The stock options vest in three equal annual installments beginning July 27, 2018.